Cardlytics Reports Q1 2026 Earnings with Declines in Billings and Revenue
Cardlytics (CDLX) reported a significant decline in billings and revenue for the first quarter of 2026, driven by ongoing challenges. Despite this, adjusted contribution margin reached a record high at 60.6%, though management expects it to decrease post-Bridg divestiture.
Tickers: $CDLX
Topics: adjusted_contribution billings cash_flow ebitda revenue